ClinicalTrials.govpublic full text
Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia
acute myeloid leukemia, actinium-225, lintuzumab, columbia, post-remission, phase i, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 865047
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.